Evidence map›Paper›PMID 19786598›Full record

ArticleAntimicrobial agents and chemotherapy2009

Spread of bla(CTX-M-14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain.

Aránzazu Valverde, Rafael Cantón, M Pilar Garcillán-Barcia, Angela Novais, Juan Carlos Galán, Andrés Alvarado, Fernando de la Cruz, Fernando Baquero, Teresa M Coque

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Article
  2. Interplay between bacterial clones and plasmids in the spread ofOne health (Amsterdam, Netherlands) · 2025
    Article
  3. Stool carriage of CTX-M/CMY-producingFrontiers in cellular and infection microbiology · 2025
    Article
  4. Plasmid-mediated acquisition and chromosomal integration ofAntimicrobial agents and chemotherapy · 2024
    Article
  5. Prevalence of CTX-M types among ESBL-producing pathogenicFood science and biotechnology · 2024
    Article
  6. Article
  7. Article
  8. ESBL/Antibiotics (Basel, Switzerland) · 2022
    Article
  9. Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2022
    Article
  10. Genomic Characterization of ESBL/AmpC-ProducingInfection and drug resistance · 2022
    Article
  11. Emergence and Spread of Cephalosporinases in Wildlife: A Review.Animals : an open access journal from MDPI · 2021
    Review
  12. Review
  13. High Prevalence and Diversity of Cephalosporin-ResistantAntibiotics (Basel, Switzerland) · 2020
    Article
  14. Article
  15. Multiple NDM-5-ExpressingOpen forum infectious diseases · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aránzazu ValverdeServicio de Microbiología, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Rafael Cantón
M Pilar Garcillán-Barcia
Angela Novais
Juan Carlos Galán
Andrés Alvarado
Fernando de la Cruz
Fernando Baquero
Teresa M Coque

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since its first description in 2000, CTX-M-14 has become one of the most widespread extended-spectrum beta-lactamases in Spain. In the present Escherichia coli multilevel population genetic study involving the characterization of phylogroups, clones, plasmids, and genetic platforms, 61 isolates from 16 hospitalized patients and 40 outpatients and healthy volunteers recovered from 2000 to 2005 were analyzed. Clonal relatedness (XbaI pulsed-field gel electrophoresis [PFGE] type, phylogenetic group, multilocus sequence type [MLST]) was established by standard methods. Analysis of transferred plasmids (I-CeuI; S1 nuclease; restriction fragment length polymorphism analysis; and analysis of RNA interference, replicase, and relaxase) was performed by PCR, sequencing, and hybridization. The genetic environment of bla(CTX-M-14) was characterized by PCR on the basis of known associated structures (ISEcp1, IS903, ISCR1). The isolates were mainly recovered from patients in the community (73.8%; 45/61) with urinary tract infections (62.2%; 28/45). They were clonally unrelated by PFGE and corresponded to phylogenetic groups A (36.1%), D (34.4%), and B1 (29.5%). MLST revealed a high degree of sequence type (ST) diversity among phylogroup D isolates and the overrepresentation of the ST10 complex among phylogroup A isolates and ST359/ST155 among phylogroup B1 isolates. Two variants of bla(CTX-M-14) previously designated bla(CTX-M-14a) (n = 59/61) and bla(CTX-M-14b) (n = 2/61) were detected. bla(CTX-M-14a) was associated with either ISEcp1 within IncK plasmids (n = 27), ISCR1 linked to an IncHI2 plasmid (n = 1), or ISCR1 linked to IncI-like plasmids (n = 3). The bla(CTX-M-14b) identified was associated with an ISCR1 element located in an IncHI2 plasmid (n = 1) or with ISEcp1 located in IncK (n = 1). The CTX-M-14-producing E. coli isolates in our geographic area are frequent causes of community-acquired urinary tract infections. The increase in the incidence of such isolates is mostly due to the dissemination of IncK plasmids among E. coli isolates of phylogroups A, B1, and D.

Indexed as

Amino Acid Sequencebeta-LactamasesEscherichia coliEscherichia coli ProteinsHumansModels, GeneticMolecular Sequence DataPhylogenyPlasmidsPolymerase Chain ReactionSequence Homology, Amino AcidSpainbeta-LactamasesEscherichia coli Proteins

Identifiers

PMID19786598
PMCPMC2786348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.